ARTIFICIALCELLS,NANOMEDICINE,ANDBIOTECHNOLOGY461
hemoglobin:comparisonwithnaturalacellularpolymerichemoglobins.
thefutureworktoensurethesafetyandfeasibilityofVcas
ArtifCellsBloodSubstitImmobilBiotechnol.38:64–68.
antioxidantinHBOCssolution.
KrukoskiDW,ComarSR,ClaroLM,LeonartMS,doNascimentoAJ.2009.
EffectofvitaminC,deferoxamine,quercetinandrutinagainsttert-butyl
hydroperoxideoxidativedamageinhumanerythrocytes.Hematology.
Declarationofinterest
14:168–172.
LiF,ZhangH,WangJ,YangC.2009.Purificationandviralinactivationof
ThisresearchwasfinanciallysupportedbytheSichuanInternational
hemoglobinfromhumanplacentablood.ArtifCellsBloodSubstit
CooperationandExchangeResearchProgram(No.2014HH0065),Sichuan
ImmobilBiotechnol.37:57–60.
ScienceandTechnologySupportProgram(No.2014SZ0123),Scientific
PutchalaMC,RamaniP,SherlinHJ,PremkumarP,NatesanA.2013.Ascorbic
ResearchProgramofSichuanProvincialHealthandFamilyPlanning
acidanditspro-oxidantactivityasatherapyfortumoursoforalcavity–
Commission(No.150256).
asystematicreview.ArchOralBiol.58:563–574.
RocheCJ,TalwarA,PalmerAF,CabralesP,GerfenG,FriedmanJM.2015.
References
Evaluatingthecapacitytogenerateandpreservenitricoxidebioactiv-
ityinhighlypurifiedearthwormerythrocruorin:agiantpolymeric
BuehlerPW,VallelienF,MikolajczykMG,SchoedonG,SchweizerT,Alayash
hemoglobinwithpotentialbloodsubstituteproperties.JBiolChem.
AI,SchaerDJ.2008.Structuralstabilizationintetramericorpolymeric
290:99–117.
hemoglobindeterminesitsinteractionwithendogenousantioxidant
SongBK,NugentWH,Moon-MassatPF,PittmanRN.2014.Effectsofa
scavengerpathways.AntioxidRedoxSignal.10:1449–1462.
hemoglobin-basedoxygencarrier(HBOC-201)andderivativeswith
ChenG,DuanY,LiS,WangH,LiuJ,YangC.2013.AntioxidanteffectsofVc
alteredoxygenaffinityandviscosityonsystemicandmicrocirculatory
onhumanplacentahemoglobin-basedoxygencarriers.The14th
variablesinatop-loadratmodel.MicrovascRes.95:124–130.
InternationalSymposiumofBloodSubstitutesandOxygen
WangQ,HuT,SunL,JiS,ZhaoD,LiuJ,MaG,SuZ.2015.CObinding
Therapeutics.Chengdu,China.
improvesthestructural,functional,physicalandanti-oxidationproper-
ChenG,MoL,LiS,ZhouW,WangH,LiuJ,YangC.2015.Separationand
tiesofthePEGylatedhemoglobin.ArtifCellsNanomedBiotechnol.
determinationofreducedvitaminCinpolymerizedhemoglobin-based
43:18–25.
oxygencarriersofthehumanplacenta.ArtifCellsNanomedBiotechnol.
WangQ,SunL,JiS,ZhaoD,LiuJ,SuZ,HuT.2014.Reversible
43:152–156.
protectionofCys-93(b)byPEGaltersthestructuralandfunctional
ChikvaidzeEN,PartskhaladzeTM,GogoladzeTV.2014.Electronspin
propertiesofthePEGylatedhemoglobin.BiochimBiophysActa.
resonance(ESR/EPR)offreeradicalsobservedinhumanredhair:a
1844:1201–1207.
new,simpleempiricalmethodofdeterminationofpheomelanin/
WinslowRM.2013.Oxygen:thepoisonisinthedose.Transfusion.
eumulaninratioinhair.MagnResonChem.52:377–382.
53:424–437.
DormanSC,KennyCF,MillerL,HirschRE,HarringtonJP.2002.Roleofredox
WuW,LiT,LiuJ,YangC.2011.Pretreatmentbeforeischemiainductionwith
potentialofhemoglobin-basedoxygencarriersonmethemoglobin
polymerizedhumanplacentahemoglobin(PolyPHb)attenuatesische-
reductionbyplasmacomponents.ArtifCellsBloodSubstitImmobil
mia/reperfusioninjury-inducedmyocardialapoptosis.ArtifCellsBlood
Biotechnol.30:39–51.
SubstitImmobilBiotechnol.39:3–6.
HaiCM.2012.SystemsbiologyofHBOC-inducedvasoconstriction.Curr
ZhouW,ZhaoL,WangJ,LiS,ChenG,LiuJ,YangC.2013.Anoptimal
DrugDiscovTechnol.9:204–211.
polymerizationconditionsforpoly-humanplacentahemoglobin
HarringtonJP,OrligK,ZitoSL,WollockoJ,WollockoH.2010.
withlowermeanmolecularweight.ArtifCellsNanomedBiotechnol.
StructuralandredoxbehaviorofOxyVita,azero-linkedpolymeric
41:289–292.
Downloadedby[TheInstituteofBloodTransfusion,ChineseAcademyofMedicalSciences]at22:3615March2016 |
|
